Navigation Links
Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego

A group of researchers led by Dr. Adam Godzik at the Burnham Institute for Medical Research is creating tools to speed up the understanding of information gathered// from the human genome project. Rich with $2.1 million funding available to them over a three year period, this consortium, under the name Joint Center for Molecular Modeling, will seek to provide adequate support to scientists from Burnham and UCSD's Computer Science and Engineering department as they team up to develop innovative software.

Researchers are sequencing millions of genes per year in different genomic projects. Solving the structures of the protein products of these genes proceeds at a slower pace of between 3,000 and 5,000 per year. Using the structures of proteins that have already been solved, Dr. Godzik and co-principal investigators Drs. Pavel Pevzner, Yuzhen Ye and Piotr Cieplak will develop novel ways to extract rules and trends of how structures change and evolve. They will use these tools to predict how, for instance, a human protein would differ from its counterpart in mice or bacteria.

"Protein structures can be solved experimentally in a couple of months, sometimes weeks," said Dr. Godzik. "Scientists around the world have already solved tens of thousands of them. Structures of many proteins can also be predicted on a computer in a matter of minutes, but the quality of such models is generally so poor that they are not useful in many applications, such as drug design. We have developed tools that allow us to learn from structures already solved and apply that knowledge to improve predicted structures of new proteins. This funding from the National Institutes of Health makes it possible for us to prove our concept and make our tools available to scientists worldwide."

"Dr. Godzik brings together an interdisciplinary team with an impressive track record," said Dr. Jerry Li, Program Director of the National Institute of General Medical Sciences a t the National Institutes of Health, which funded the new project. "By developing and using new computational approaches, the group will improve our ability to accurately model the three-dimensional structures of proteins, which are invaluable to functional studies and rational drug design."

Adam Godzik, Ph.D., is Professor and Director of the Bioinformatics and Systems Biology Program at the Burnham Institute for Medical Research. Yuzhen Ye, Ph.D., and Piotr Cieplak, Ph.D., are Research Assistant Professor and Staff Scientist, respectively, at the Burnham. Pavel Pevzner, Ph.D., is the Ronald R. Taylor Professor of Computer Science in the Department of Computer Science and Engineering at UCSD's Jacobs School of Engineering.

According to Pevzner, predicting protein structures represents a rich source of new algorithmic challenges. "In recent years new mathematical tools have revolutionized the way we describe rearrangements of genomic elements and domain reshuffling in multi-domain proteins," said Pevzner. "We believe that they can also be used to recognize and describe the movements of micro-domains in protein structures, and that will be the focus of the Computer Science and Engineering department's participation in this collaboration with the Burnham Institute."

Source :Eureka Alert


'"/>




Related medicine news :

1. New Treatment For Hip Joints
2. Joint replacement surgery outcomes may be affected by obesity and diabetes
3. New combined therapy for Knee Joint pain
4. New Hereditary Bone Joint Disorder Identified
5. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
6. A Joint Venture by Golfers And Military Forces To Combat AIDS
7. Asian Nations To Take Joint Efforts Against H5N1
8. Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals
9. Increase in the Demand for Artificial Joints
10. Joint Effort among Various Nations to Tackle Bird Flu
11. Joint Research by IIT-K and GSVM
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... planning assistance from offices in Pasco and Richland, is initiating a charity drive ... serious injuries resulting from a recent automobile collision. , On October 29th ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I have gout, and ... this old family recipe, which is meant to relieve gout and pain caused by ... a 12-hour energy boost every time. It relieved what VA doctors called the worst ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... proudly announced today that a new solution for Emergency Departments (ED) has been ... tight space in Emergency Department examination rooms, and with a simplified pallet of ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology: